UNSPSC 51343301: Xenazoic acid

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51343301

Definition

This classification denotes an antiviral agent with the molecular formula C23H21NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KDU8VH09O8, chemically known as benzoic acid, p-(alpha-ethoxy-p-phenylphenacylamino)- but generally known as xenazoic acid, which bears US NIH Compound Identifier 239062. European Medicines Agency schedules Xenazoic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00101MIG.

Read the full definition

The term XENAZOIC ACID is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). Most nations schedule xenazoic acid under HS 29225000 and SITC 51467. As of Q4 2014, XENAZOIC ACID remains the US FDA Preferred Term for this commodity. Xenazoic acid bears US NLM identifiers UMLS ID C1883571 and NCI Concept Code C66662. SMILES: O(C(NC1CCC(CC1)C(=O)O)C(=O)C1CCC(CC1)C1CCCCC1)CC.

About UNSPSC 51343301

UNSPSC 51343301 Xenazoic acid is a Commodity code that, based on recent state and local solicitations, frames pharmaceutical products procured through emergency preparedness and public health supply chains. The code shows limited alignment with its narrow nominal scope; recent opportunities tagged under this code involve naloxone, doxycycline hyclate, and ciprofloxacin hydrochloride — antibiotics and opioid-overdose reversal agents rather than xenazoic acid itself. State and local buyers are using this code to flag pharmaceutical warehouse and emergency-response acquisitions through piggyback cooperative purchasing agreements and competitive bidding. Issuing bodies include state health departments and county governments seeking to stock pharmaceuticals for public health emergency response and community health initiatives. The procurement pathway typically involves Invitation for Bid (IFB) notices or piggyback awards through established pharmaceutical consortia such as MMCAP Infuse.

Activity is concentrated in Illinois and Florida. The Illinois Department of Public Health awarded a completed $2,999,999.11 three-year piggyback contract to Chartwell Rx LLC through MMCAP Infuse on August 28, 2026, for doxycycline hyclate 100mg tablets and ciprofloxacin hydrochloride 500mg tablets (Solicitation 26482DPHPREPDB53392). Seminole County, Florida issued an IFB on June 30, 2026 (Solicitation IFB60459723LAS) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023, and quarterly delivery requirements to the Seminole County Community Health Building in Sanford. Neither opportunity required small-business set-asides or veterans preferences. Code usage appears sparse; the mismatch between the code's nominal scope and the actual pharmaceutical products recently solicited suggests state and local procurement offices are applying this Commodity code as a catch-all for pharmaceutical procurement rather than for xenazoic acid specifically.

Quick answers

What is UNSPSC 51343301?

UNSPSC 51343301 is Xenazoic acid, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51343301?

UNSPSC 51343301 maps to 1 NIGP code, 26908 Anti-Infective Agents.

On GovTribe

See everything under UNSPSC 51343301

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code